(Q36216863)

12 August 2017

1 reference

title

Effects of weight loss and pharmacotherapy on inflammatory markers of cardiovascular disease (English)

1 reference

12 August 2017

0 references

Wendy M Miller

1

1 reference

12 August 2017

Katherine E Nori Janosz

series ordinal

2

1 reference

12 August 2017

Jose Yanez

series ordinal

3

1 reference

12 August 2017

Peter A McCullough

series ordinal

4

1 reference

12 August 2017

publication date

1 July 2005

1 reference

Expert Review of Cardiovascular Therapy

12 August 2017

published in

1 reference

12 August 2017

volume

3

1 reference

12 August 2017

issue

4

1 reference

12 August 2017

page(s)

743-759

1 reference

Inflammation in atherosclerosis

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

A novel pathway to the manifestations of metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Adipocytokines and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

The adipose tissue as a source of vasoactive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Glitazones and the management of insulin resistance: what they do and how might they be used

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Interleukin-6 and the acute phase response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

C-reactive protein: a critical update

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Cytokine-induced alteration of platelet and hemostatic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Abdominal obesity and dyslipidemia in the metabolic syndrome: importance of type 2 diabetes and familial combined hyperlipidemia in coronary artery disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Obesity wars: molecular progress confronts an expanding epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Leptin can induce proliferation, differentiation, and functional activation of hemopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Leptin potentiates IFN-gamma-induced expression of nitric oxide synthase and cyclo-oxygenase-2 in murine macrophage J774A.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Severe hypercholesterolemia, hypertriglyceridemia, and atherosclerosis in mice lacking both leptin and the low density lipoprotein receptor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Independent association between plasma leptin and C-reactive protein in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Circulating tumor necrosis factor alpha concentrations are higher in abdominal versus peripheral obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Insulin resistance in adipose tissue: direct and indirect effects of tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Increased adipose angiotensinogen gene expression in human obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Role of NAD(P)H oxidase in angiotensin II-induced JAK/STAT signaling and cytokine induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Adiponectin: A novel adipokine linking adipocytes and vascular function

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Adiponectin: more than just another fat cell hormone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Association of hypoadiponectinemia with impaired vasoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Hypoadiponectinemia is closely linked to endothelial dysfunction in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Adiponectin stimulates production of nitric oxide in vascular endothelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Minireview: The adipocyte--at the crossroads of energy homeostasis, inflammation, and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Of mice and men (and women) and the acylation-stimulating protein pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

High triglycerides and low HDL cholesterol and blood pressure and risk of ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

C-reactive protein predicts progression of atherosclerosis measured at various sites in the arterial tree: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Adiponectin gene expression in subcutaneous adipose tissue of obese women in response to short-term very low calorie diet and refeeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Adiponectin, inflammation, and the expression of the metabolic syndrome in obese individuals: the impact of rapid weight loss through caloric restriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Energy restriction and weight loss on very-low-fat diets reduce C-reactive protein concentrations in obese, healthy women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effects of hypocaloric diet and exercise training on inflammation and adipocyte lipolysis in obese postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

The effects of physical activity on serum C-reactive protein and inflammatory markers: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Weight loss leads to reductions in inflammatory biomarkers after a very-low-carbohydrate diet and a low-fat diet in overweight men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Improved glycemic control and lipid profile and normalized fibrinolytic activity on a low-glycemic index diet in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Treatment for the procoagulant state in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Dietary weight loss decreases serum angiotensin-converting enzyme activity in obese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Use of portion-controlled entrees enhances weight loss in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Pharmacological approaches to weight reduction: therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effects of low-dose aspirin on serum C-reactive protein and thromboxane B2 concentrations: a placebo-controlled study using a highly sensitive C-reactive protein assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effect of clopidogrel added to aspirin before percutaneous coronary intervention on the risk associated with C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Pharmacologic blockade of the renin-angiotensin system: vascular benefits beyond commonly understood pharmacologic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Relationship between effects of statins, aspirin and angiotensin II modulators on high-sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effects of atorvastatin on glucose homeostasis, postprandial triglyceride response and C-reactive protein in subjects with impaired fasting glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Comparison of effect of intensive lipid lowering with atorvastatin to less intensive lowering with lovastatin on C-reactive protein in patients with stable angina pectoris and inducible myocardial ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effects of statins on the vasculature: Implications for aggressive lipid management in the cardiovascular metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

A pharmacoepidemiological assessment of the effect of statins and fibrates on fibrinogen concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Severe hypertriglyceridemia with insulin resistance is associated with systemic inflammation: reversal with bezafibrate therapy in a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Treatment of severe hypertriglyceridemia lowers plasma viscosity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effects of rosiglitazone on endothelial function, C-reactive protein, and components of the metabolic syndrome in nondiabetic patients with the metabolic syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effects of rosiglitazone alone and in combination with atorvastatin on the metabolic abnormalities in type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Antiatherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its antidiabetic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Metabolic syndrome: evaluation of pathological and therapeutic outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Diet, insulin resistance, and obesity: zoning in on data for Atkins dieters living in South Beach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Pancreatic islets from type 2 diabetic patients have functional defects and increased apoptosis that are ameliorated by metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14779072.3.4.743

21 January 2018

Identifiers

DOI

10.1586/14779072.3.4.743

1 reference

12 August 2017

1 reference